174 related articles for article (PubMed ID: 28202223)
1. Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups.
Awe JA; Saranchuk J; Drachenberg D; Mai S
Urol Oncol; 2017 May; 35(5):300-309. PubMed ID: 28202223
[TBL] [Abstract][Full Text] [Related]
2. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
Lustberg MB; Balasubramanian P; Miller B; Garcia-Villa A; Deighan C; Wu Y; Carothers S; Berger M; Ramaswamy B; Macrae ER; Wesolowski R; Layman RM; Mrozek E; Pan X; Summers TA; Shapiro CL; Chalmers JJ
Breast Cancer Res; 2014 Mar; 16(2):R23. PubMed ID: 24602188
[TBL] [Abstract][Full Text] [Related]
4. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenic potential of circulating prostate tumor cells.
Carvalho FL; Simons BW; Antonarakis ES; Rasheed Z; Douglas N; Villegas D; Matsui W; Berman DM
Oncotarget; 2013 Mar; 4(3):413-21. PubMed ID: 23530114
[TBL] [Abstract][Full Text] [Related]
6. Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells.
Warkiani ME; Guan G; Luan KB; Lee WC; Bhagat AA; Chaudhuri PK; Tan DS; Lim WT; Lee SC; Chen PC; Lim CT; Han J
Lab Chip; 2014 Jan; 14(1):128-37. PubMed ID: 23949794
[TBL] [Abstract][Full Text] [Related]
7. Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line.
Lazar DC; Cho EH; Luttgen MS; Metzner TJ; Uson ML; Torrey M; Gross ME; Kuhn P
Phys Biol; 2012 Feb; 9(1):016002. PubMed ID: 22306736
[TBL] [Abstract][Full Text] [Related]
8. Analogous detection of circulating tumor cells using the AccuCyte
van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer.
Politaki E; Agelaki S; Apostolaki S; Hatzidaki D; Strati A; Koinis F; Perraki M; Saloustrou G; Stoupis G; Kallergi G; Spiliotaki M; Skaltsi T; Lianidou E; Georgoulias V; Mavroudis D
Cell Physiol Biochem; 2017; 44(2):594-606. PubMed ID: 29161698
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
Bobek V; Gurlich R; Eliasova P; Kolostova K
World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
[TBL] [Abstract][Full Text] [Related]
12. Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B).
Yamamichi F; Matsuoka T; Shigemura K; Kawabata M; Shirakawa T; Fujisawa M
Urology; 2012 Oct; 80(4):951.e1-7. PubMed ID: 22920407
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
14. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of three-dimensional telomere profiles of circulating tumor cells in patients with high-risk prostate cancer who are undergoing androgen deprivation and radiation therapies.
Wark L; Klonisch T; Awe J; LeClerc C; Dyck B; Quon H; Mai S
Urol Oncol; 2017 Mar; 35(3):112.e1-112.e11. PubMed ID: 27956006
[TBL] [Abstract][Full Text] [Related]
16. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
[TBL] [Abstract][Full Text] [Related]
17. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.
Chen JF; Ho H; Lichterman J; Lu YT; Zhang Y; Garcia MA; Chen SF; Liang AJ; Hodara E; Zhau HE; Hou S; Ahmed RS; Luthringer DJ; Huang J; Li KC; Chung LW; Ke Z; Tseng HR; Posadas EM
Cancer; 2015 Sep; 121(18):3240-51. PubMed ID: 25975562
[TBL] [Abstract][Full Text] [Related]
18. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device.
Yin C; Wang Y; Ji J; Cai B; Chen H; Yang Z; Wang K; Luo C; Zhang W; Yuan C; Wang F
Anal Chem; 2018 Mar; 90(6):3744-3751. PubMed ID: 29464943
[TBL] [Abstract][Full Text] [Related]
19. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
20. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
